The effect of taxifolin on oxidative ovarian damage and reproductive dysfunctions induced by antipsychotic drugs in female rats
article
OA: closed
CC0
Abstract
AIM: Typical antipsychotics (TAPs) are commonly used to treat schizophrenia and bipolar disorder. However, extrapyramidal disorders, hyperprolactinemia, and reproductive dysfunctions have been observed in women during the use of TAPs. For this reason, less toxic and prolactin-sparing atypical antipsychotic (AAP) drugs such as clozapine (CLN) have been developed. The aim of this study is to investigate the effect of taxifolin on possible ovarian and reproductive toxicity associated with CLN and haloperidol (HPL) in female Wistar albino rats. METHODS: The rats were grouped as healthy control group (HCG), CLN, HPL, taxifolin + clozapine (TCL), and taxifolin + haloperidol (THL). Drugs were administered to the groups for 28 days. At the end of that time, ovarian tissues of six rats from each group were taken for histopathological and biochemical analyses. Remaining six rats in groups were examined for evaluation of reproductive dysfunctions. RESULTS: Severe degeneration and vacuolization were observed in the primary, secondary, and primordial follicles of the ovarian tissues of CLN- and HPL-treated groups, of which malondialdehyde (MDA) level was high and total glutathione (tGSH) level was low. In the taxifolin-treated groups, taxifolin significantly prevented the increase of MDA level and decrease of tGSH level, and the severity of histopathological damage was found to be lower. In addition, it was found that taxifolin significantly prevented infertility and delay in pregnancy associated with CLN and HPL. CONCLUSIONS: The results of this experiment suggest that taxifolin can be beneficial in treating oxidative ovarian damage, infertility, and reproductive dysfunctions induced by CLN and HPL.
My notes (saved in your browser only)
Condition tags
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
References (31)
- doi:10.31887/dcns.2018.20.1/klrooney via openalex
- doi:10.1016/0003-2697(79)90738-3 via openalex
- doi:10.1016/j.neuropharm.2006.07.006 via openalex
- doi:10.1080/10520295.2019.1703219 via openalex
- doi:10.1007/s00210-011-0641-y via openalex
- doi:10.1016/j.tiv.2017.07.008 via openalex
- doi:10.1358/mf.2007.29.3.1075355 via openalex
- doi:10.1006/abio.1976.9999 via openalex
- doi:10.1016/j.toxlet.2017.03.018 via openalex
- doi:10.1093/mutage/gei043 via openalex
- doi:10.1093/ajcn/72.2.637s via openalex
- doi:10.1016/s0021-9258(18)47552-7 via openalex
- doi:10.1055/s-2006-957530 via openalex
- doi:10.1016/0891-5849(95)02227-9 via openalex
- W2297845641 via openalex
- W2442049182 via openalex
- doi:10.1016/s0165-1781(02)00123-3 via openalex
- doi:10.1016/0003-2697(68)90092-4 via openalex
- doi:10.1016/s2305-0500(13)60127-x via openalex
- doi:10.1007/bf02977772 via openalex
- doi:10.1155/2015/598162 via openalex
- doi:10.1515/jbcpp-2018-0230 via openalex
- doi:10.4149/gpb_2019006 via openalex
- W6763571075 via openalex
- W7073985950 via openalex
- doi:10.1007/s00441-019-03067-x via openalex
- doi:10.3389/fphar.2018.01286 via openalex
- doi:10.1016/0003-2697(76)90527-3 via openalex
- doi:10.4149/gpb_20190281 via openalex
- doi:10.1080/14767058.2019.1706469 via openalex
- doi:10.1080/01616412.2016.1251711 via openalex
Source provenance
- openalex
- last seen: 2026-05-10T10:19:58.985210+00:00
License: CC0
· commercial use OK